Results 71 to 80 of about 13,942 (180)

Amantadine-induced bilateral corneal edema: A case report and literature review

open access: yesIndian Journal of Ophthalmology. Case Reports
We report a case of amantadine-induced bilateral corneal edema that was initially suspected as herpes simplex keratitis in a 47-year-old female patient taking amantadine for neurological disease.
Ching-Liang Kuo
doaj   +1 more source

Progress of Immunotherapies in Parkinson's Disease

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 6, June 2026.
Parkinson's disease (PD) is caused by an immune disorder triggered by α‐synuclein, leading to a persistent neuroinflammatory cycle that drives the disease from non‐motor symptoms to the motor stage. Second, it presents active and passive immunotherapy strategies targeting α‐synuclein and their potential in slowing down the disease progression.
Yong Peng   +10 more
wiley   +1 more source

Previous Creatinine Levels Safely Predict Amantadine Dose for Influenza a Outbreak Control

open access: yesCanadian Journal of Infectious Diseases, 2001
BACKGROUND: Amantadine, an antiviral agent, is the only drug currently approved in Canada for prophylaxis of influenza A virus infection. To minimize side effects, the amantadine dose is adjusted for age and estimated creatinine clearance (CrCl) based on
Jane A Buxton   +7 more
doaj   +1 more source

Paracetamol prescribing to small animals by veterinarians in Australia and New Zealand

open access: yesAustralian Veterinary Journal, Volume 104, Issue 6, Page 327-333, June 2026.
Objective To describe the prescribing patterns of paracetamol by veterinarians in Australia and New Zealand. Methods An online survey was created and distributed to veterinarians in Australia and New Zealand over a 3‐month period (July–October 2024).
A Tse, W Chee, CJ Boyd, CR Sharp
wiley   +1 more source

Amantadine: an antiviral and antiparkinsonian agent

open access: yesVeterinární Medicína, 2001
Amantadine is an antiviral agent that specifically inhibits influenza A virus replication at a micromolar concentration. This drug is also very effective in the treatment of human Parkinson's disease.
J. Staničová   +2 more
doaj   +1 more source

Parkinson's Disease and Salivary Issues: A Survey

open access: yesGerodontology, Volume 43, Issue 2, Page 234-244, June 2026.
ABSTRACT Background Salivary dysfunction, including xerostomia and drooling, is common in Parkinson's disease and further impairs oral health and quality of life, which are already compromised in this population. Their effective management demands deeper insight into the complexity of salivary dysfunction.
Beau D. M. van Dijk   +3 more
wiley   +1 more source

Antiviral Resistance in Influenza: Clinical and Public Health Implications

open access: yesInfluenza and Other Respiratory Viruses, Volume 20, Issue 6, June 2026.
ABSTRACT Timely antiviral treatment and prevention can diminish the morbidity and mortality caused by influenza seasonal, zoonotic, and pandemic infections. However, the emergence of antiviral resistance threatens the utility of available agents and sometimes contributes to poor clinical outcomes.
Jinghao Nicholas Ngiam   +2 more
wiley   +1 more source

Use of amantadine in traumatic brain injury: an updated meta-analysis of randomized controlled trials

open access: yesFrontiers in Neurology
IntroductionAmantadine has been shown to accelerate cognitive and functional brain recovery after cerebrovascular accidents. However, the efficacy of this drug in TBI patients remains poorly defined.MethodsWe performed a systematic review and meta ...
João Félix   +4 more
doaj   +1 more source

Does amantadine induce acute psychosis? A case report and literature review

open access: yesNeuropsychiatric Disease and Treatment, 2016
Wei-juan Xu,1,2 Ning Wei,1,2 Yi Xu,1,2 Shao-hua Hu1,2 1Department of Psychiatry, The First Affiliated Hospital of Zhejiang University School of Medicine, 2The Key Laboratory of Mental Disorder’s Management of Zhejiang Province, Hangzhou ...
xu W, Wei N, Xu Y, Hu S
doaj  

Home - About - Disclaimer - Privacy